RxNorm Semantic Concepts Index - 236
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "236".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 236 | acidulated phosphate fluoride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360030 | Pleurotus eryngii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360031 | Taiwanofungus camphoratus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360032 | Senecio scandens flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236006 | Carphenazine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236006 | Carphenazine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2360130 | 2-(N-morpholino)ethanesulfonic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360131 | 6-tert-butyl-3-methyl-2,4-dinitroanisole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360132 | Agaricus blazei whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360133 | aluminum nitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360134 | Astragalus mongholicus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360135 | ammonium hypophosphite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360136 | Angelica biserrata whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360230 | Vitex negundo flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360231 | sacituzumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360231 | sacituzumab | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2360231 | sacituzumab | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2360232 | sacituzumab govitecan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2360232 | sacituzumab govitecan | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2360232 | sacituzumab govitecan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2360232 | sacituzumab govitecan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2360232 | sacituzumab govitecan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2360233 | thioglycolic acid triethanolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236025 | Bovine heparin sodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236025 | Bovine heparin sodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236025 | Bovine heparin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2360330 | linoleamidopropyl propylene glycol-dimonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360331 | lubabegron | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360430 | N-((ethoxycarbonyl)methyl)-p-menthane-3-carboxamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360431 | zinc alum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360432 | triethanolamine acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2360433 | glycorine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360434 | heptanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23605 | Dolichol kinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23605 | Dolichol kinase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2360530 | sacituzumab govitecan-hziy | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2360531 | sacituzumab govitecan-hziy 180 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2360532 | sacituzumab Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2360532 | sacituzumab Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2360532 | sacituzumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2360533 | sacituzumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2360534 | sacituzumab govitecan-hziy 180 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360534 | sacituzumab govitecan-hziy 180 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2360535 | Trodelvy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2360536 | sacituzumab govitecan-hziy 180 MG [Trodelvy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2360537 | sacituzumab Injection [Trodelvy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2360538 | Trodelvy Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2360539 | TRODELVY 180 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2360539 | TRODELVY 180 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360539 | TRODELVY 180 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360540 | sodium starch glycolate type A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360541 | octreotide 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2360542 | octreotide Pen Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2360543 | octreotide 2500 MCG/ML in 2.8 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2360543 | octreotide 2500 MCG/ML in 2.8 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360543 | octreotide 2500 MCG/ML in 2.8 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360543 | octreotide 2500 MCG/ML in 2.8 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360544 | Bynfezia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2360545 | octreotide 2.5 MG/ML [Bynfezia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2360546 | octreotide Pen Injector [Bynfezia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2360547 | Bynfezia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2360548 | Bynfezia 2500 MCG/ML in 2.8 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2360548 | Bynfezia 2500 MCG/ML in 2.8 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360548 | Bynfezia 2500 MCG/ML in 2.8 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360548 | Bynfezia 2500 MCG/ML in 2.8 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360549 | octreotide 2.5 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360550 | octreotide 2.5 MG/ML Pen Injector [Bynfezia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360550 | octreotide 2.5 MG/ML Pen Injector [Bynfezia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2360571 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360572 | Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360573 | Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360574 | Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360576 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2360577 | Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2360578 | Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2360579 | Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 236058 | Cefepime hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236058 | Cefepime hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236058 | Cefepime hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2360580 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2360581 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2360582 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2360583 | meningococcal (groups A, C, Y and W-135) polysaccharide tetanus toxoid conjugate vaccine 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2360583 | meningococcal (groups A, C, Y and W-135) polysaccharide tetanus toxoid conjugate vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360583 | meningococcal (groups A, C, Y and W-135) polysaccharide tetanus toxoid conjugate vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360584 | Menquadfi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2360585 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML [Menquadfi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2360586 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine Injection [Menquadfi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2360587 | Menquadfi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2360588 | MenQuadfi vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2360588 | MenQuadfi vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360588 | MenQuadfi vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360588 | MenQuadfi vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360589 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360590 | Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.02 MG/ML Injection [Menquadfi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2360593 | chlorhexidine acetate 4.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2360594 | chlorhexidine acetate 0.45 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360594 | chlorhexidine acetate 0.45 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360594 | chlorhexidine acetate 0.45 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360605 | acetaminophen 500 MG / aspirin 500 MG / caffeine 65 MG Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360605 | acetaminophen 500 MG / aspirin 500 MG / caffeine 65 MG Oral Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2360605 | acetaminophen 500 MG / aspirin 500 MG / caffeine 65 MG Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360606 | Firstflush | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2360607 | water 983 MG/ML [Firstflush] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2360608 | water Ophthalmic Irrigation Solution [Firstflush] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2360609 | Firstflush Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2360610 | Firstflush 98.3 % Ophthalmic Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360610 | Firstflush 98.3 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360610 | Firstflush 98.3 % Ophthalmic Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360610 | Firstflush 98.3 % Ophthalmic Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2360630 | Domeboro Cooling | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2360631 | aluminum acetate 0.005 MG/MG [Domeboro Cooling] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2360632 | aluminum acetate Topical Gel [Domeboro Cooling] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2360633 | Domeboro Cooling Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2360634 | Domeboro Cooling 0.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2360634 | Domeboro Cooling 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360634 | Domeboro Cooling 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360634 | Domeboro Cooling 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360641 | benzalkonium chloride 0.0015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2360642 | didecyldimethylammonium chloride 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2360643 | polyaminopropyl biguanide 0.01 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2360644 | benzalkonium / didecyldimethylammonium chloride / polyaminopropyl biguanide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2360645 | benzalkonium / didecyldimethylammonium chloride / polyaminopropyl biguanide Topical Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2360646 | benzalkonium / didecyldimethylammonium chloride / polyaminopropyl biguanide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2360647 | benzalkonium chloride 0.15 % / didecyldimethylammonium chloride 0.5 % / polyaminopropyl biguanide 1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360647 | benzalkonium chloride 0.15 % / didecyldimethylammonium chloride 0.5 % / polyaminopropyl biguanide 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360647 | benzalkonium chloride 0.15 % / didecyldimethylammonium chloride 0.5 % / polyaminopropyl biguanide 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236065 | Dorzolamide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236065 | Dorzolamide hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236065 | Dorzolamide hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236066 | Moexipril hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236066 | Moexipril hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236066 | Moexipril hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236069 | Nalmefene hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236069 | Nalmefene hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236069 | Nalmefene hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236074 | strychnine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236077 | cyclosporine, modified | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236077 | cyclosporine, modified | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 236081 | Valaciclovir hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236081 | Valaciclovir hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236081 | Valaciclovir hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236081 | Valaciclovir hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236081 | Valaciclovir hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 236082 | Nefazodone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236082 | Nefazodone hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236082 | Nefazodone hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236083 | Alendronic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236083 | Alendronic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236083 | Alendronic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236083 | Alendronic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236083 | Alendronic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236084 | sulfathiazole sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2360875 | benzalkonium chloride 0.15 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360875 | benzalkonium chloride 0.15 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360875 | benzalkonium chloride 0.15 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360876 | benzalkonium chloride 0.12 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360876 | benzalkonium chloride 0.12 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360876 | benzalkonium chloride 0.12 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360883 | doxycycline hyclate 80 MG [Doryx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2360884 | DORYX 80 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360884 | DORYX 80 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360884 | DORYX 80 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2360889 | Cymbopogon winterianus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360890 | dimethyl myristamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2360891 | Amanita pantherina fruiting body extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360893 | Plectranthus amboinicus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2360896 | ethanol 0.715 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2360897 | ethanol 71.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360897 | ethanol 71.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360897 | ethanol 71.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360898 | ethanol 66 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360898 | ethanol 66 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360898 | ethanol 66 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360899 | polyethylene glycol 400 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360899 | polyethylene glycol 400 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360899 | polyethylene glycol 400 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2360900 | polyethylene glycol 400 / tetrahydrozoline / zinc sulfate Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2360901 | polyethylene glycol 400 / tetrahydrozoline / zinc sulfate Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2360902 | polyethylene glycol 400 / tetrahydrozoline / zinc sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2360903 | polyethylene glycol 400 1 % / tetrahydrozoline hydrochloride 0.05 % / zinc sulfate 0.25 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2360903 | polyethylene glycol 400 1 % / tetrahydrozoline hydrochloride 0.05 % / zinc sulfate 0.25 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360903 | polyethylene glycol 400 1 % / tetrahydrozoline hydrochloride 0.05 % / zinc sulfate 0.25 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2360903 | polyethylene glycol 400 1 % / tetrahydrozoline hydrochloride 0.05 % / zinc sulfate 0.25 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2360918 | ethanol 72 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360918 | ethanol 72 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2360918 | ethanol 72 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360919 | benzalkonium Cl 0.2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2360919 | benzalkonium Cl 0.2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2360919 | benzalkonium Cl 0.2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 236092 | Somatostatin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236092 | Somatostatin acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236092 | Somatostatin acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236099 | Domperidone maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236099 | Domperidone maleate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236099 | Domperidone maleate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2361 | Chlorhexidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2361 | Chlorhexidine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2361 | Chlorhexidine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236104 | Cefpirome sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236104 | Cefpirome sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236104 | Cefpirome sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236104 | Cefpirome sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361056 | ethanol 66 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361056 | ethanol 66 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361056 | ethanol 66 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361057 | ethanol 0.684 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2361058 | ethanol 68.4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361058 | ethanol 68.4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361058 | ethanol 68.4 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236106 | poison ivy extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236109 | Acetylsalicylate DL-lysine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236109 | Acetylsalicylate DL-lysine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236109 | Acetylsalicylate DL-lysine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236112 | Caffeine monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236112 | Caffeine monohydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236112 | Caffeine monohydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236115 | Tetracosactide acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236115 | Tetracosactide acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236115 | Tetracosactide acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236120 | Indecainide hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236120 | Indecainide hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236121 | Echinacea angustifolia whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236121 | Echinacea angustifolia whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236122 | ethylnicotinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236124 | deanol bitartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236125 | Diclofenac diethylamine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236125 | Diclofenac diethylamine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236125 | Diclofenac diethylamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236125 | Diclofenac diethylamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236127 | Motherwort | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236127 | Motherwort | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2361281 | ethanol 0.737 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2361282 | ethanol 73.7 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361282 | ethanol 73.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361282 | ethanol 73.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361285 | tucatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2361285 | tucatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2361285 | tucatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2361285 | tucatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2361285 | tucatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2361286 | tucatinib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2361287 | tucatinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2361287 | tucatinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2361287 | tucatinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2361288 | tucatinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2361289 | tucatinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2361290 | tucatinib 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2361290 | tucatinib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2361290 | tucatinib 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2361290 | tucatinib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2361291 | Tukysa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2361292 | tucatinib 150 MG [Tukysa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2361293 | tucatinib Oral Tablet [Tukysa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2361294 | Tukysa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2361295 | Tukysa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2361296 | TUKYSA 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2361296 | TUKYSA 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2361296 | TUKYSA 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2361297 | tucatinib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2361298 | tucatinib 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2361298 | tucatinib 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2361298 | tucatinib 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2361298 | tucatinib 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2361299 | tucatinib 50 MG [Tukysa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2361300 | TUKYSA 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2361300 | TUKYSA 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2361300 | TUKYSA 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2361301 | cholesteryl macadamiate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2361302 | fenugreek seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2361303 | Zoletil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2361304 | tiletamine 50 MG/ML / zolazepam 50 MG/ML [Zoletil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361305 | tiletamine / zolazepam Injectable Solution [Zoletil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2361306 | Zoletil Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2361307 | Zoletil 50 MG/ML / 50 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361307 | Zoletil 50 MG/ML / 50 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2361307 | Zoletil 50 MG/ML / 50 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361308 | hypromellose 2208 (750 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2361309 | acrylic acid/2-ethylhexyl acrylate/styrene copolymer (500000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236131 | codeine anhyd | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2361310 | nimodipine 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2361310 | nimodipine 6 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2361311 | niMODipine 6 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2361311 | niMODipine 6 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2361311 | niMODipine 6 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2361311 | niMODipine 6 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2361311 | niMODipine 6 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2361311 | niMODipine 6 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2361311 | niMODipine 6 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2361312 | nimodipine 6 MG/ML [Nymalize] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2361312 | nimodipine 6 MG/ML [Nymalize] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2361313 | Nymalize 6 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2361313 | Nymalize 6 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2361313 | Nymalize 6 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2361313 | Nymalize 6 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2361313 | Nymalize 6 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2361313 | Nymalize 6 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236133 | spongia tosta | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236137 | Titanium peroxide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236137 | Titanium peroxide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236138 | Titanium salicylate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236138 | Titanium salicylate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236140 | trifluperidol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236142 | zinc aspartate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236146 | dextromethorphan polistirex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236149 | amyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236152 | bamifylline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236154 | black currant preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236155 | butalamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236156 | Fumaria officinalis extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236156 | Fumaria officinalis extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236156 | Fumaria officinalis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236156 | Fumaria officinalis extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236157 | Alizapride hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236157 | Alizapride hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236158 | aprindine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2361587 | camphor 3.1 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361587 | camphor 3.1 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361587 | camphor 3.1 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361596 | selumetinib sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2361596 | selumetinib sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2361596 | selumetinib sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236160 | Hydroconchinine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236160 | Hydroconchinine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236160 | Hydroconchinine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236160 | Hydroconchinine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236161 | hydroxyestrone diacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2361615 | ethanol 0.78 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2361616 | ethanol 78 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361616 | ethanol 78 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361616 | ethanol 78 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236163 | Iproniazid phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236163 | Iproniazid phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2361638 | pyrilamine maleate 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2361641 | carbetapentane citrate 60 MG / guaifenesin 1200 MG [Certuss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361641 | carbetapentane citrate 60 MG / guaifenesin 1200 MG [Certuss] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2361646 | ethanol 80 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361646 | ethanol 80 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361646 | ethanol 80 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361648 | carbetapentane citrate 4 MG/ML / guaifenesin 20 MG/ML [Betavent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361648 | carbetapentane citrate 4 MG/ML / guaifenesin 20 MG/ML [Betavent] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2361657 | carbetapentane citrate 4 MG/ML / guaifenesin 20 MG/ML [Carba XP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361657 | carbetapentane citrate 4 MG/ML / guaifenesin 20 MG/ML [Carba XP] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2361661 | carbetapentane citrate 4 MG/ML / guaifenesin 20 MG/ML [Pulmari-GP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361661 | carbetapentane citrate 4 MG/ML / guaifenesin 20 MG/ML [Pulmari-GP] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2361664 | carbetapentane citrate 2 MG/ML / guaifenesin 20 MG/ML [Exall] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361664 | carbetapentane citrate 2 MG/ML / guaifenesin 20 MG/ML [Exall] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2361668 | carbetapentane tannate 6 MG/ML [Solotuss] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 236167 | lanreotide acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236167 | lanreotide acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236167 | lanreotide acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2361671 | acetaminophen 500 MG / phenyltoloxamine citrate 60 MG [Alpain] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361675 | acetaminophen 32 MG/ML / phenyltoloxamine citrate 1 MG/ML [Relagesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361684 | acetaminophen 650 MG / phenyltoloxamine citrate 50 MG [Relagesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361688 | acetaminophen 650 MG / phenyltoloxamine citrate 50 MG [Rhinoflex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361691 | magnesium salicylate 600 MG / phenyltoloxamine citrate 25 MG [Mobigesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361693 | magnesium salicylate 600 MG / phenyltoloxamine citrate 25 MG [Magsal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361695 | magnesium salicylate 600 MG / phenyltoloxamine citrate 25 MG [Miogesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361697 | magnesium salicylate 600 MG / phenyltoloxamine citrate 25 MG [Tetra-Mag] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2361700 | rough cocklebur pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2361702 | Kentucky bluegrass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2361705 | meadow fescue grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 236172 | pirisudanol maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236174 | prifinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236175 | camylofin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236176 | captodiamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236177 | clofexamide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236178 | nadoxolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236179 | mefenorex hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236180 | cyclobutyrol sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2361827 | isodecyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2361830 | benzalkonium chloride 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361830 | benzalkonium chloride 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361830 | benzalkonium chloride 10 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361832 | chloroxylenol 0.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361832 | chloroxylenol 0.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361832 | chloroxylenol 0.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361833 | isopropyl alcohol 0.776 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2361834 | isopropyl alcohol 77.6 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2361834 | isopropyl alcohol 77.6 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361834 | isopropyl alcohol 77.6 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361843 | hypochlorous acid 0.06 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2361844 | hypochlorous acid 0.006 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2361844 | hypochlorous acid 0.006 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2361844 | hypochlorous acid 0.006 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 236185 | sultopride hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236186 | Tenonitrozole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236186 | Tenonitrozole | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236186 | Tenonitrozole | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236188 | Tiemonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236188 | Tiemonium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236188 | Tiemonium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236189 | Trimipramine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236189 | Trimipramine mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236189 | Trimipramine mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236189 | Trimipramine mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236190 | Tropatepine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236190 | Tropatepine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236190 | Tropatepine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236194 | deanol bisorcate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236195 | Deanol pyroglutamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236195 | Deanol pyroglutamate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236195 | Deanol pyroglutamate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236195 | Deanol pyroglutamate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236196 | ferrous oxalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236199 | micronomicin sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236200 | Midecamycin diacetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236200 | Midecamycin diacetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236200 | Midecamycin diacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236200 | Midecamycin diacetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2362001 | Calotropis procera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2362002 | Carapa procera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2362008 | menthol 1.4 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2362008 | menthol 1.4 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2362008 | menthol 1.4 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2362010 | benzocaine / menthol / zinc chloride Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2362011 | benzocaine / menthol / zinc chloride Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2362012 | benzocaine / menthol / zinc chloride Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2362013 | benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2362013 | benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362013 | benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236202 | cefotiam hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236204 | cetiedil citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236205 | clobenzorex hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236206 | diisopromine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236208 | difemerine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236209 | dihexyverine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236210 | dihexyverine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236213 | ethanolamine thenoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236215 | etifoxine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236216 | Eformoterol fumarate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236216 | Eformoterol fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236216 | Eformoterol fumarate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236216 | Eformoterol fumarate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362165 | capmatinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2362165 | capmatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362165 | capmatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362165 | capmatinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362165 | capmatinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362166 | cyclohexanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2362167 | Opicapone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2362167 | Opicapone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362167 | Opicapone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362167 | Opicapone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362167 | Opicapone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362168 | opicapone 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2362169 | Opicapone-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2362169 | Opicapone-containing product in oral dose form | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362169 | Opicapone-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362170 | opicapone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2362171 | opicapone Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2362172 | opicapone 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362172 | opicapone 25 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362172 | opicapone 25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2362172 | opicapone 25 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362173 | Ongentys | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2362174 | opicapone 25 MG [Ongentys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2362175 | opicapone Oral Capsule [Ongentys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2362176 | Ongentys Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2362177 | Ongentys Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2362178 | Ongentys 25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362178 | Ongentys 25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362178 | Ongentys 25 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2362179 | opicapone 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2362180 | opicapone 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362180 | opicapone 50 MG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362180 | opicapone 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2362180 | opicapone 50 MG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362181 | opicapone 50 MG [Ongentys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2362182 | Ongentys 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362182 | Ongentys 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362182 | Ongentys 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2362183 | Alpha-pinene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2362183 | Alpha-pinene | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362183 | Alpha-pinene | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362183 | Alpha-pinene | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362183 | Alpha-pinene | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362184 | 1,2,3-propanetriol, 2-(4-aminobenzoate) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2362185 | 2-methyl-1,2-benzoisothiazolin-3-one | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236219 | alibendol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23622 | Dolomite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23622 | Dolomite | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236220 | ammonium salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2362230 | capmatinib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2362231 | capmatinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2362231 | capmatinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362231 | capmatinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362232 | capmatinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2362233 | capmatinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2362234 | capmatinib 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362234 | capmatinib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362234 | capmatinib 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362234 | capmatinib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2362234 | capmatinib 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362235 | Tabrecta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2362236 | capmatinib 150 MG [Tabrecta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2362237 | capmatinib Oral Tablet [Tabrecta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2362238 | Tabrecta Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2362239 | Tabrecta Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2362240 | TABRECTA 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2362240 | TABRECTA 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362240 | TABRECTA 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362240 | TABRECTA 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362241 | capmatinib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2362242 | capmatinib 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362242 | capmatinib 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362242 | capmatinib 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2362242 | capmatinib 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2362242 | capmatinib 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2362243 | capmatinib 200 MG [Tabrecta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2362244 | TABRECTA 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2362244 | TABRECTA 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362244 | TABRECTA 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362244 | TABRECTA 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362245 | Cistanche tinctoria stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2362246 | Bifidobacterium animalis 16000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2362247 | Lactobacillus acidophilus 16 Billion UNT / Bifidobacterium animalis 16 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362247 | Lactobacillus acidophilus 16 Billion UNT / Bifidobacterium animalis 16 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2362247 | Lactobacillus acidophilus 16 Billion UNT / Bifidobacterium animalis 16 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2362247 | Lactobacillus acidophilus 16 Billion UNT / Bifidobacterium animalis 16 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2362250 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 20 mL Oral Solution) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| Concept ID (RxCUI): 2362250 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 20 mL Oral Solution) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2362250 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 20 mL Oral Solution) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2362250 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 20 mL Oral Solution) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2362250 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 20 mL Oral Solution) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2362252 | hypochlorous acid 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2362253 | hypochlorous acid 0.005 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2362253 | hypochlorous acid 0.005 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2362253 | hypochlorous acid 0.005 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2362254 | isopropyl alcohol 60 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2362254 | isopropyl alcohol 60 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2362254 | isopropyl alcohol 60 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2362257 | ethanol 67 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2362257 | ethanol 67 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2362257 | ethanol 67 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2362259 | capmatinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236229 | Fenticonazole nitrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236229 | Fenticonazole nitrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236229 | Fenticonazole nitrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23623 | domiphen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23623 | domiphen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23623 | domiphen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23623 | domiphen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23623 | domiphen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236233 | quinagolide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236233 | quinagolide hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236233 | quinagolide hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236234 | Gemcitabine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236234 | Gemcitabine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236234 | Gemcitabine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236236 | codeine camsyl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236237 | hordenine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236238 | burdock root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236248 | Amylmetacresol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236248 | Amylmetacresol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236248 | Amylmetacresol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236248 | Amylmetacresol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236248 | Amylmetacresol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236249 | parethoxycaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236250 | parethoxycaine HCl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236251 | cyamemazine tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236252 | Horse blood extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236252 | Horse blood extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236254 | Tianeptine sodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236254 | Tianeptine sodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236259 | potassium glucoheptonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236260 | diphenhydramine diacefyllinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236260 | diphenhydramine diacefyllinate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 236265 | isomyrtol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236268 | biclotymol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236268 | biclotymol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236268 | biclotymol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236268 | biclotymol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236268 | biclotymol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236274 | keracyanin chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236277 | Calcium lactate gluconate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236277 | Calcium lactate gluconate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236277 | Calcium lactate gluconate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236277 | Calcium lactate gluconate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236279 | Harpagophytum procumbens root preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236279 | Harpagophytum procumbens root preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236281 | Fenspiride hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236281 | Fenspiride hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236281 | Fenspiride hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236286 | Emulsifying wax | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236286 | Emulsifying wax | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236292 | heptaminol acefyllinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236293 | Heptaminol 5'-adenylate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236293 | Heptaminol 5'-adenylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236293 | Heptaminol 5'-adenylate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236293 | Heptaminol 5'-adenylate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236294 | Heptaminol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236294 | Heptaminol hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236294 | Heptaminol hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236297 | chlorproethazine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2363 | Chloride peroxidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2363 | Chloride peroxidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236300 | acetiamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236301 | acetiamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236302 | Hydroxocobalamin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236302 | Hydroxocobalamin acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236302 | Hydroxocobalamin acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236303 | isospaglumic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236310 | Eprazinone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236310 | Eprazinone hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236310 | Eprazinone hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236314 | guaiacol ethylglycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236315 | guaietolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236318 | Menthyl valerate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236318 | Menthyl valerate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236324 | magnesium glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236327 | quinine ascorbate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236327 | quinine ascorbate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 236328 | maprotiline mesylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236329 | muramidase hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236340 | Alexitol sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236340 | Alexitol sodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236340 | Alexitol sodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236343 | viquidil hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236344 | Saw palmetto extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236344 | Saw palmetto extract | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236344 | Saw palmetto extract | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236346 | dimecrotic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236347 | dimecrotic acid magnesium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236348 | morpholine salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236354 | phenylbutazone piperazine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236356 | Picloxydine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236356 | Picloxydine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236356 | Picloxydine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236359 | synephrine tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236361 | Tilia | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236361 | Tilia | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236361 | Tilia | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236361 | Tilia | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236364 | adrenalone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236368 | sarsaparilla preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236374 | tertatolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236374 | tertatolol hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236374 | tertatolol hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236379 | Rilmenidine phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236379 | Rilmenidine phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236379 | Rilmenidine phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23638 | dopexamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23638 | dopexamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23638 | dopexamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23638 | dopexamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23638 | dopexamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236380 | Piribedil mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236380 | Piribedil mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236380 | Piribedil mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236380 | Piribedil mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236380 | Piribedil mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236381 | Poractant alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236381 | Poractant alfa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236381 | Poractant alfa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236381 | Poractant alfa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236381 | Poractant alfa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236383 | Ritiometan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236383 | Ritiometan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236384 | Ritiometan magnesium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236384 | Ritiometan magnesium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236387 | fenoxazoline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236388 | L-menthol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236388 | L-menthol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236388 | L-menthol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236388 | L-menthol | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236388 | L-menthol | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236388 | L-menthol | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236393 | miristalkonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236394 | miristalkonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236395 | methyl diacetylcysteinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236396 | naringin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236398 | Myrtecaine lauryl sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236398 | Myrtecaine lauryl sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236400 | minaprine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236401 | meglumine benzoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236405 | Urapidil hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236405 | Urapidil hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236407 | tricarbaurinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236408 | Tiliquinol lauryl sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236408 | Tiliquinol lauryl sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236410 | palmitoyl collagen acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236420 | magnesium thiosulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236421 | mefenidramium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236422 | mefenidramium methylsulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236423 | Pralidoxime methyl sulfate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236423 | Pralidoxime methyl sulfate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236439 | pancreas extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236440 | sodium methylcamphorate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236445 | rutin sodium sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236449 | propylene glycol salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236452 | di-isopropylammonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236455 | propinox HCl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236455 | propinox HCl | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236457 | chloropyramine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236459 | Tromantadine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236459 | Tromantadine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236459 | Tromantadine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236460 | Tizanidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236460 | Tizanidine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236460 | Tizanidine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 236460 | Tizanidine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236461 | propylhexedrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236463 | glicofosfopeptical | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236464 | Metamizole magnesium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236464 | Metamizole magnesium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236464 | Metamizole magnesium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236465 | dehydroemetine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236466 | Pygeum africanum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236467 | Bassorin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236468 | norfenefrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236471 | protamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236474 | Fexofenadine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236474 | Fexofenadine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236474 | Fexofenadine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236475 | Rifamycin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236475 | Rifamycin sodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236475 | Rifamycin sodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236477 | diatrizoate lysine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236481 | mephentermine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236486 | Omeprazole magnesium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236486 | Omeprazole magnesium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236486 | Omeprazole magnesium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236487 | pipazetate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236495 | Tamsulosin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236495 | Tamsulosin hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236495 | Tamsulosin hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236502 | tribasic potassium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236508 | Pyritinol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236508 | Pyritinol hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236508 | Pyritinol hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236509 | uridine triphosphate sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 23651 | doxacurium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23651 | doxacurium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23651 | doxacurium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23651 | doxacurium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23651 | doxacurium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236510 | Metformin embonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236510 | Metformin embonate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236510 | Metformin embonate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236512 | aminohydroxybutyric acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236514 | Gadoteric acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236514 | Gadoteric acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236514 | Gadoteric acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236514 | Gadoteric acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236517 | Phenoxymethyl penicillin calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236517 | Phenoxymethyl penicillin calcium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236517 | Phenoxymethyl penicillin calcium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236517 | Phenoxymethyl penicillin calcium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236517 | Phenoxymethyl penicillin calcium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236519 | bampine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236522 | clostebol acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236525 | cyproheptadine pyrid phos | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236526 | sodium acexamate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236528 | fenproporex hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236529 | phenylbutazone sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236530 | bamipine lactate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236531 | Buchu | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236531 | Buchu | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236531 | Buchu | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236532 | cyprodenate maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236534 | camylofin bis(noramid-mes) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236537 | rutin sodium propylsulfonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236538 | Triptorelin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236538 | Triptorelin acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236538 | Triptorelin acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236539 | Ropivacaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236539 | Ropivacaine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236539 | Ropivacaine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 236539 | Ropivacaine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236540 | Remifentanyl hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236540 | Remifentanyl hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236540 | Remifentanyl hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236540 | Remifentanyl hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236541 | Dihydralazine mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236541 | Dihydralazine mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236541 | Dihydralazine mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236542 | Benzoylquinine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236542 | Benzoylquinine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236542 | Benzoylquinine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236543 | roxatidine acetate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236543 | roxatidine acetate hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236543 | roxatidine acetate hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236549 | dequalinium salicylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 23655 | Doxophylline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23655 | Doxophylline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23655 | Doxophylline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23655 | Doxophylline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23655 | Doxophylline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236553 | Ropinirole hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236553 | Ropinirole hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236553 | Ropinirole hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 236553 | Ropinirole hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236554 | oxilofrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236558 | Butenafine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236558 | Butenafine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236558 | Butenafine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236559 | Donepezil hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236559 | Donepezil hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236559 | Donepezil hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236560 | calcium dihydrogen phosphate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236564 | magnesium gluconogluceptate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236572 | meclofenoxate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236573 | lithium hydrogen aspartate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236583 | mite extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236587 | thenoate lithium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236594 | Amphotericin B liposome | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236594 | Amphotericin B liposome | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236594 | Amphotericin B liposome | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236595 | Acebrophylline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236595 | Acebrophylline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236595 | Acebrophylline | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236595 | Acebrophylline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236595 | Acebrophylline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236595 | Acebrophylline | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236599 | Olopatadine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236599 | Olopatadine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236599 | Olopatadine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236601 | sertaconazole nitrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236601 | sertaconazole nitrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236601 | sertaconazole nitrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236608 | glucosamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236612 | Anagrelide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236612 | Anagrelide hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236612 | Anagrelide hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236614 | butcher's broom preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236615 | propicillin potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236617 | ferrous aspartate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23663 | doxycycline hyclate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 23663 | doxycycline hyclate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 23663 | doxycycline hyclate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236632 | pantoprazole (as pantoprazole sodium sesquihydrate) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236632 | pantoprazole (as pantoprazole sodium sesquihydrate) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236632 | pantoprazole (as pantoprazole sodium sesquihydrate) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236634 | ethyl cysteine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236641 | Capsella bursa-pastoris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236641 | Capsella bursa-pastoris whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236644 | pholedrine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236646 | insulin, protamine zinc, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236647 | Doxycycline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236647 | Doxycycline hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236647 | Doxycycline hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236648 | Fosfomycin disodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236648 | Fosfomycin disodium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236648 | Fosfomycin disodium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236649 | procyanidolic oligomer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23665 | doxylamine succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236650 | Fluprednidene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236650 | Fluprednidene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236650 | Fluprednidene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236650 | Fluprednidene | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236650 | Fluprednidene | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236651 | fenethylline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236652 | phenmetrazine theoclate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236658 | botulism antitoxin A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236660 | botulism antitoxin E | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236664 | chaste tree fruit extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236664 | chaste tree fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236665 | Black cohosh extract | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236669 | choline stearate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236673 | moxaverine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236674 | dienogest / ethinyl estradiol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 236677 | 2-phenylphenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236677 | 2-phenylphenol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236677 | 2-phenylphenol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236677 | 2-phenylphenol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236677 | 2-phenylphenol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236679 | morazone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236680 | dihydroergotamine tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236681 | tiropramide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236685 | Memantine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236685 | Memantine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236685 | Memantine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236690 | Naratriptan hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236690 | Naratriptan hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236690 | Naratriptan hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236693 | calcium saccharate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236699 | Rubus idaeus leaf preparation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236699 | Rubus idaeus leaf preparation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236701 | clebopride maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236710 | prothipendyl hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236713 | theofibrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236718 | sulfonated phenol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236719 | dibasic sodium phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236719 | dibasic sodium phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236730 | simaldrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236734 | amitriptyline oxide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236738 | nicotinic acid propyl ester | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2367408 | 3,5,5-trimethylhexanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2367409 | Quinghaosu | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236741 | Epsom salt | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236741 | Epsom salt | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236741 | Epsom salt | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236741 | Epsom salt | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236741 | Epsom salt | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2367430 | triethanolamine caproyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2367438 | ethanol 0.648 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2367439 | ethanol 64.8 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2367439 | ethanol 64.8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2367439 | ethanol 64.8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2367440 | golotimod | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2367441 | impacarzine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236747 | Pramipexole dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236747 | Pramipexole dihydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236747 | Pramipexole dihydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236749 | benproperine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236749 | benproperine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236749 | benproperine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236749 | benproperine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236749 | benproperine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236750 | benproperine pamoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236757 | phospholipid,beef | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236758 | oxyfedrine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236767 | fendiline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236768 | sulfated mucopolysaccharides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236769 | thymopentin acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236770 | talniflumate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236771 | perazine dimalonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236774 | flupirtine maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2367753 | ethanol 0.751 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2367754 | ethanol 75.1 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2367754 | ethanol 75.1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2367754 | ethanol 75.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2367755 | ethanol 78 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2367755 | ethanol 78 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2367755 | ethanol 78 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2367757 | remdesivir 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2367758 | remdesivir 100 MG in 20 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2367758 | remdesivir 100 MG in 20 mL Injection | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2367758 | remdesivir 100 MG in 20 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2367758 | remdesivir 100 MG in 20 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2367758 | remdesivir 100 MG in 20 mL Injection | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2367759 | remdesivir 5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2367760 | benzalkonium chloride 0.1 % / ethanol 80 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2367760 | benzalkonium chloride 0.1 % / ethanol 80 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2367760 | benzalkonium chloride 0.1 % / ethanol 80 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2367761 | Achlys triphylla whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2367762 | hexacosyl glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2367763 | acid violet 9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236778 | Trospium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236778 | Trospium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236778 | Trospium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236778 | Trospium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236778 | Trospium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2367781 | european olive pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2367784 | orchard grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2367786 | redroot pigweed pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2367788 | short ragweed pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2367790 | perennial rye grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2367792 | Timothy grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2367795 | velvet grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2367797 | benzocaine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2367798 | benzocaine 10 % Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2367798 | benzocaine 10 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2367798 | benzocaine 10 % Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2367799 | benzocaine Oral Suspension [OraMagic Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 23678 | dromostanolone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23678 | dromostanolone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23678 | dromostanolone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23678 | dromostanolone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23678 | dromostanolone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2367800 | OraMagic Plus Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2367801 | OraMagic Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 236781 | medifoxamine fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236782 | Saccharomyces boulardii | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236782 | Saccharomyces boulardii | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236782 | Saccharomyces boulardii | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236782 | Saccharomyces boulardii | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236782 | Saccharomyces boulardii | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236784 | detajmium bitartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236785 | uridine monophosphate disodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236785 | uridine monophosphate disodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236787 | azidocillin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236790 | ribonucleic acid sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236792 | phenyltoloxamine polistirex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236794 | denaverine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236795 | demelverin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236796 | demelverine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236797 | alpha hydroxy acids | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2368 | Chlorisondamine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2368 | Chlorisondamine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236801 | yohimbe bark preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236802 | damiana extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236803 | pyridoxine phosphoserinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236806 | bupranolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236807 | dibenzepin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236809 | maidenhair tree extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368125 | (3-chloropropyl)trimethoxysilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2368126 | Gamma tocopherol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2368126 | Gamma tocopherol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2368126 | Gamma tocopherol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2368126 | Gamma tocopherol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2368126 | Gamma tocopherol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2368127 | 1-octenylsuccinic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2368128 | dextromethorphan HBr 20 MG / guaiFENesin 375 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2368128 | dextromethorphan HBr 20 MG / guaiFENesin 375 MG / pseudoephedrine HCl 60 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2368128 | dextromethorphan HBr 20 MG / guaiFENesin 375 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2368128 | dextromethorphan HBr 20 MG / guaiFENesin 375 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2368128 | dextromethorphan HBr 20 MG / guaiFENesin 375 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2368131 | poliglusam hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236815 | promethazine dioxide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236816 | neo-homosalate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2368180 | ethanol 0.728 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2368181 | ethanol 72.8 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2368181 | ethanol 72.8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2368181 | ethanol 72.8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368182 | ethanol 66 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2368182 | ethanol 66 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2368182 | ethanol 66 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368183 | ethanol 0.887 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2368184 | ethanol 88.7 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2368184 | ethanol 88.7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2368184 | ethanol 88.7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368185 | ethanol 73.7 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2368185 | ethanol 73.7 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2368185 | ethanol 73.7 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368186 | benzalkonium chloride 0.003 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2368187 | benzalkonium chloride 0.3 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2368187 | benzalkonium chloride 0.3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2368187 | benzalkonium chloride 0.3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236829 | arbutamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 23683 | dromostanolone propionate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 23683 | dromostanolone propionate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23683 | dromostanolone propionate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236832 | sulfachrysoidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236833 | sulfachrysoidine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236834 | zinc nicotinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 23684 | drotaverine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 23684 | drotaverine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23684 | drotaverine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23684 | drotaverine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23684 | drotaverine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23684 | drotaverine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2368456 | ePHEDrine sulfate 50 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2368456 | ePHEDrine sulfate 50 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2368456 | ePHEDrine sulfate 50 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2368456 | ePHEDrine sulfate 50 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2368456 | ePHEDrine sulfate 50 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2368457 | Emerphed | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2368458 | ephedrine sulfate 5 MG/ML [Emerphed] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2368458 | ephedrine sulfate 5 MG/ML [Emerphed] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2368459 | ephedrine Injection [Emerphed] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2368459 | ephedrine Injection [Emerphed] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2368460 | Emerphed Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2368461 | Emerphed 50 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2368461 | Emerphed 50 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2368461 | Emerphed 50 MG in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2368461 | Emerphed 50 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2368461 | Emerphed 50 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2368462 | ephedrine sulfate 5 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2368462 | ephedrine sulfate 5 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2368463 | ephedrine sulfate 5 MG/ML Injection [Emerphed] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368463 | ephedrine sulfate 5 MG/ML Injection [Emerphed] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2368463 | ephedrine sulfate 5 MG/ML Injection [Emerphed] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 236847 | erythromycin stinoprate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236850 | ictasol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2368530 | diphenhydramine Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2368530 | diphenhydramine Shampoo Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2368531 | diphenhydramine Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2368531 | diphenhydramine Medicated Shampoo | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2368532 | diphenhydrAMINE HCl 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2368532 | diphenhydrAMINE HCl 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368532 | diphenhydrAMINE HCl 1 % Medicated Shampoo | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2368532 | diphenhydrAMINE HCl 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2368532 | diphenhydrAMINE HCl 1 % Medicated Shampoo | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2368533 | sulfur Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2368534 | sulfur Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2368536 | disodium EDTA-copper CU-64 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236855 | Lactobacillus bifidus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236857 | valepotriate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236858 | gepefrine tartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236859 | Estradiol hemihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236859 | Estradiol hemihydrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236859 | Estradiol hemihydrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236860 | cathine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236861 | cathine polistirex | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236862 | Grepafloxacin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236862 | Grepafloxacin hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236862 | Grepafloxacin hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236864 | cloconazole hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236865 | Butinoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236865 | Butinoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236866 | Butinoline phosphate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236866 | Butinoline phosphate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236867 | octodrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236868 | octodrine camsylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236869 | pridinol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 23687 | droxicam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236872 | 8-chlorotheophylline | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 236872 | 8-chlorotheophylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236873 | tetracycline trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2368732 | dibromantin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2368732 | dibromantin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2368733 | semuloparin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236875 | Tiagabine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236875 | Tiagabine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236875 | Tiagabine hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 236875 | Tiagabine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236876 | thymus gland-calf | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236878 | Eprosartan mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236878 | Eprosartan mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236878 | Eprosartan mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236878 | Eprosartan mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236880 | ethyl hexyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236881 | butoxycaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236883 | nebivolol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236883 | nebivolol hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236883 | nebivolol hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236888 | bunazosin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236889 | bisdequalinium diacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236892 | budipine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236896 | prajmalium bitartrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236897 | tyramine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2369 | Chlormadinone acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2369 | Chlormadinone acetate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2369 | Chlormadinone acetate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236900 | corticorelin human triflutate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236901 | Somatorelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236901 | Somatorelin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236903 | bopindolol hydrogen malonate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236904 | mepindolol sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236907 | potassium sulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236908 | methyl butetisalicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236911 | Zinc citrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236911 | Zinc citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 236911 | Zinc citrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236911 | Zinc citrate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236911 | Zinc citrate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236913 | levomethadone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236913 | levomethadone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236913 | levomethadone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236914 | levomethadone HCl | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236916 | Ibandronate sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236916 | Ibandronate sodium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236916 | Ibandronate sodium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236917 | Sodium pantothenate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236917 | Sodium pantothenate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236917 | Sodium pantothenate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236919 | Clocortolone hexanoate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236919 | Clocortolone hexanoate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236926 | theobromine sod salicylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236930 | 4-dimethylaminophenol hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236931 | hydrocodone hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236931 | hydrocodone hydrochloride | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2369351 | ethanol 74 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2369351 | ethanol 74 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2369351 | ethanol 74 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2369353 | allo-2-hydroxycitric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2369354 | benzyl alcohol 10 % / lidocaine HCl 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2369354 | benzyl alcohol 10 % / lidocaine HCl 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2369354 | benzyl alcohol 10 % / lidocaine HCl 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2369358 | Leonurus japonicus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369360 | Liriodendron tulipifera whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369366 | Opuntia tuna whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369367 | PPG-2-ceteth-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369372 | Ulmus glabra pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369380 | Crassostrea gigas shell extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369382 | polyethylene glycol 400 / propylene glycol Ophthalmic Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2369383 | polyethylene glycol 400 0.4 % / propylene glycol 0.3 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2369383 | polyethylene glycol 400 0.4 % / propylene glycol 0.3 % Ophthalmic Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2369384 | Ocusan Dry Eyes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2369385 | polyethylene glycol 400 4 MG/ML / propylene glycol 3 MG/ML [Ocusan Dry Eyes] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2369386 | polyethylene glycol 400 / propylene glycol Ophthalmic Suspension [Ocusan Dry Eyes] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2369387 | Ocusan Dry Eyes Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2369388 | Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2369388 | Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2369388 | Ocusan Dry Eyes 0.4 % / 0.3 % Ophthalmic Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2369389 | ripretinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2369389 | ripretinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2369389 | ripretinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2369389 | ripretinib | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2369389 | ripretinib | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2369390 | zinc sulfate 1 MG in ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2369390 | zinc sulfate 1 MG in ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2369390 | zinc sulfate 1 MG in ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2369393 | ripretinib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2369394 | ripretinib Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2369394 | ripretinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2369394 | ripretinib Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2369395 | ripretinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2369396 | ripretinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2369397 | ripretinib 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2369397 | ripretinib 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2369397 | ripretinib 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2369397 | ripretinib 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2369398 | Qinlock | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2369399 | ripretinib 50 MG [Qinlock] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2369400 | ripretinib Oral Tablet [Qinlock] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2369401 | Qinlock Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2369402 | Qinlock Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2369403 | QINLOCK 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2369403 | QINLOCK 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2369403 | QINLOCK 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2369406 | methyl salicylate 0.6 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2369407 | camphor / capsaicin / methyl salicylate Topical Oil | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2369408 | camphor 10 % / capsaicin 0.025 % / methyl salicylate 60 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2369408 | camphor 10 % / capsaicin 0.025 % / methyl salicylate 60 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2369408 | camphor 10 % / capsaicin 0.025 % / methyl salicylate 60 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236948 | phenylalanine,DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 23695 | dTDP-L-rhamnose synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23695 | dTDP-L-rhamnose synthetase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23695 | dTDP-L-rhamnose synthetase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23695 | dTDP-L-rhamnose synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236953 | guarana preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2369555 | melatonin 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2369556 | melatonin 12 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2369556 | melatonin 12 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 236960 | drotaverine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236960 | drotaverine hydrochloride | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236960 | drotaverine hydrochloride | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236961 | epinastine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236961 | epinastine hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236961 | epinastine hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236962 | benzoxonium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236962 | benzoxonium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236962 | benzoxonium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2369634 | benzalkonium / benzocaine / menthol / zinc chloride Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2369635 | benzalkonium / benzocaine / menthol / zinc chloride Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2369636 | benzalkonium / benzocaine / menthol / zinc chloride Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2369637 | benzalkonium / benzocaine / menthol / zinc chloride | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2369638 | benzalkonium chloride 0.13 % / benzocaine 20 % / menthol 0.5 % / zinc chloride 0.15 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2369638 | benzalkonium chloride 0.13 % / benzocaine 20 % / menthol 0.5 % / zinc chloride 0.15 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2369638 | benzalkonium chloride 0.13 % / benzocaine 20 % / menthol 0.5 % / zinc chloride 0.15 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2369639 | midamaline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 236964 | bismuth chloride oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369640 | midamaline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369641 | vinyl neodecanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 23697 | Deoxythymidine diphosphate-glucose 4,6 dehydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23697 | Deoxythymidine diphosphate-glucose 4,6 dehydratase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23697 | Deoxythymidine diphosphate-glucose 4,6 dehydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 23698 | Deoxythymidine monophosphate kinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 23698 | Deoxythymidine monophosphate kinase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 23698 | Deoxythymidine monophosphate kinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236980 | Silver nanoparticle | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236980 | Silver nanoparticle | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236982 | greater celandine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369827 | 2-ethylhexyl glycidyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369829 | steareth-25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2369831 | amylase 164 UNT/MG / lipase 25.5 UNT/MG / protease 139 UNT/MG [PancrePlus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2369832 | amylase / lipase / protease Oral Powder [PancrePlus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2369833 | PancrePlus Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2369834 | PancrePlus 71,400 UNT / 460,000 UNT / 388,000 UNT per 2.8 GM Oral Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2369834 | PancrePlus 71,400 UNT / 460,000 UNT / 388,000 UNT per 2.8 GM Oral Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2369834 | PancrePlus 71,400 UNT / 460,000 UNT / 388,000 UNT per 2.8 GM Oral Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 236987 | Mangafodipir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236987 | Mangafodipir | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236987 | Mangafodipir | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236987 | Mangafodipir | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 236987 | Mangafodipir | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 236988 | white bryony extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 236991 | Clopidogrel hydrogen sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 236991 | Clopidogrel hydrogen sulfate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 236991 | Clopidogrel hydrogen sulfate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 236991 | Clopidogrel hydrogen sulfate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2369930 | ethanol 0.742 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2369931 | ethanol 74.2 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2369931 | ethanol 74.2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2369931 | ethanol 74.2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 236999 | helicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |